Search - tctmd.com

Displaying 181 - 200 of 422

Sort: Relevancy | Date

Presentation THT 2023

Advanced Heart Failure in ACHD - How Do We Define It?

Presenter: Christopher Learn

March 20, 2023

News Daily News

Second Recall in Less Than 2 Months for Cardiosave IABPs

L.A. McKeown

March 17, 2023

News Conference News ACC 2023

STELLAR, ‘Impressive’ Results With Novel Drug Sotatercept in PAH

Shelley Wood

March 06, 2023

News Conference News ACC 2023

BETTER CARE-HF: Embedded EHR Alert Boosts MRA Prescribing in HFrEF

L.A. McKeown

March 06, 2023

Presentation ACC 2023

Impact of Heart Failure Management Using Thoracic Fluid Monitoring From A Novel Wearable Sensor: Results of the Benefits of Microcor (μCor™) in Ambulatory Heart Failure (BMAD) Trial

Presenter: John P. Boehmer

March 05, 2023

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Daily News

Acute Cardiac Events More Common in COVID-19 Patients With Heart Histories

Caitlin E. Cox

February 10, 2023

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

News Daily News

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

Michael O'Riordan

January 30, 2023

News Daily News

New IABP Recall: Balloon Catheter Damage Might Cause Bleeding Into Pump

Shelley Wood

January 25, 2023

News Daily News

Angioedema Risk No Higher With ARNI Than With ACE Inhibitors, ARBs

Todd Neale

January 23, 2023

News Daily News

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

L.A. McKeown

January 13, 2023

News Daily News

Even When Eligible, Not All Acute HF Patients Get GDMT

Todd Neale

January 11, 2023

News Daily News

Top Heart Failure News of 2022

Shelley Wood

January 04, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

Advertisement

Advanced Heart Failure in ACHD - How Do We Define It?

Second Recall in Less Than 2 Months for Cardiosave IABPs

STELLAR, ‘Impressive’ Results With Novel Drug Sotatercept in PAH

BETTER CARE-HF: Embedded EHR Alert Boosts MRA Prescribing in HFrEF

Impact of Heart Failure Management Using Thoracic Fluid Monitoring From A Novel Wearable Sensor: Results of the Benefits of Microcor (μCor™) in Ambulatory Heart Failure (BMAD) Trial

What’s Going to Be Hot at ACC/WCC 2023?

February 2023 News Roundup

Acute Cardiac Events More Common in COVID-19 Patients With Heart Histories

Vast Majority of HFrEF Patients Eligible for Vericiguat

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

New IABP Recall: Balloon Catheter Damage Might Cause Bleeding Into Pump

Angioedema Risk No Higher With ARNI Than With ACE Inhibitors, ARBs

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

Even When Eligible, Not All Acute HF Patients Get GDMT

Top Heart Failure News of 2022

The Biggest News of 2022: TCTMD’s Top 10

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content